Concepedia

Author

Shahedeh Karimi

Royan InstituteORCID

Also Known As

S Hahedeh Karimi, SHAHEDEH KARIMI, Shahedeh Karimi, Shahedeh karimi, Somaye Karimi

18

Publications

244

Citations

7

H-Index

24

Concepts

All Affiliations

Royan InstituteAcademic Center for Education, Culture and ResearchIsfahan University of Medical SciencesIran University of Medical SciencesShahid Beheshti University of Medical Sciences
SK

About

Shahedeh Karimi is an author at Royan Institute specializing in medicine, stem cell research, and regenerative medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

135

2

Health Sciences

1

1

99

3

Public Health

1

1

14

4

Biomedical Engineering

1

1

99

5

Cell Biology

1

1

22

Shahedeh Karimi

×

6

Publications

224

Citations

6

H-Index

YearCitations

Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

Antonio Uccelli, Alice Laroni, Rehiana Ali,

The Lancet Neurology

2021

99

Evaluation of the Shear Bond Strength and Antibacterial Activity of Orthodontic Adhesive Containing Silver Nanoparticle, an In-Vitro Study

Ladan Eslamian, Ali Borzabadi‐Farahani, Shahedeh Karimi,

Nanomaterials

2020

68

Autologous bone marrow–derived CD133 cells with core decompression as a novel treatment method for femoral head osteonecrosis: a pilot study

Mohsen Emadedin, Shahedeh Karimi, Aliasghar Karimi,

Cytotherapy

2018

22

COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran

Seyed Massood Nabavi, Mehrnoosh Mehrabani, Leila Ghalichi,

Vaccines

2022

14

Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I.

Amir Bajouri, Dorsa Dayani, Anoushe Taj Sharghi,

PubMed

2023

11

Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis Patients, Single-Center, Prospective, Open-Label, Single-Arm Clinical Trial, Long-Term Follow-up.

Seyed Massood Nabavi, Shahedeh Karimi, Leila Arab,

PubMed

2021

10

Page 1